South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnosis (Laboratory Tests, and Imaging Tests), and Indication (Pain & Cramping, Diarrhea, Constipation, and Alternating Constipation & Diarrhea)

Publication Month: May 2021 | Report Code: TIPRE00022437 | No. of Pages: 112 | Category: Medical Device | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The South and Central America irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028.

The growth of the market is determined due to some of the key driving factors, such as increasing prevalence of irritable bowel syndrome and associated conditions and advancements in diagnostics of syndrome. On the other hand, challenges in diagnosis of IBS are likely to restraint the growth of market during the forecast years.

Irritable bowel syndrome is a chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. People across the world are witnessing considerable incidence of irritable bowel syndrome. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. As per statistics by IBS Global Impact Report, in 2016, Latin America had an estimated IBS prevalence rate of 17.5%. Such staggering prevalence of irritable bowel syndrome is likely to boost the irritable bowel syndrome (IBS) diagnostics market during the forecast period. To cope up against irritable bowel syndrome, the companies involved in the drug development for irritable bowel syndrome are taking constructive steps to create awareness programs with an aim to spread awareness amongst the population. Such initiatives are anticipated to drive the growth of the irritable bowel syndrome (IBS) diagnostics market. Also, increasing number of FDA approvals and diagnostics development activities are likely to accelerate the growth of the irritable bowel syndrome (IBS) diagnostics market during the forecast period.

With the spread of the COVID-19 pandemic, it was discovered that a significant number of people around the world were suffering from irritable bowel syndrome (IBS), as COVID-19 pandemic has affected the psychological health of people, resulting in a higher level of stress. Stress can exaggerate the symptoms of irritable bowel syndrome (IBS). Thus, the impact of COVID-19 is so far considered positive on the market. Therefore, the growing demand for irritable bowel syndrome (IBS) diagnostics in South and Central America is likely to boost the growth of the irritable bowel syndrome (IBS) diagnostics market.

Get more information on this report :

 

SOUTH AND CENTRAL AMERICA IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS MARKET SEGMENTATION

By Diagnosis

  • Laboratory Tests
    • Lactose Intolerance Tests
    • Breath Test for Bacterial Overgrowth
    • Stool Tests
    • Stool Tests
  • Imaging Tests
    • CT Scan or X-ray
    • Upper Endoscopy
    • Upper Endoscopy

By Indication

  • Pain and Cramping
  • Diarrhea
  • Constipation
  • Alternating Constipation and Diarrhea

By Country

  • Brazil
  • Argentina
  •  Rest of South and Central America

Company Profiles

  • Commonwealth Diagnostics International
  • Genova Diagnostics
  • Inova Diagnostics, Inc
  • Biohit Oyj
  • Aerodiagnostics, LLC.
  • Sysmex Corporation (Sysmex Europe GmbH)

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – By Diagnosis

1.3.2        South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market – By Indication

1.3.3        South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market– By County

2.           Irritable Bowel Syndrome (IBS) Diagnostics Market– Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        SCAM PEST Analysis

4.3         Expert Opinion

5.           Irritable Bowel Syndrome (IBS) Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions

5.1.2        Increasing Number of FDA Approvals and Diagnostics Developments

5.2         Market Restraint

5.2.1        Challenges in Diagnosis of IBS

5.3         Market Opportunity

5.3.1        Increasing Disposable Incomes of the Population

5.4         Future Trend

5.4.1        Development of Medical Devices for the Diagnosis of Irritable Bowel Syndrome

5.5         Impact analysis

6.           Irritable Bowel Syndrome (IBS) Diagnostics Market– South and Central America Analysis

6.1         South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Forecast and Analysis

7.           Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis– by Diagnosis

7.1         Overview

7.2         Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)

7.3         Laboratory Tests

7.3.1        Overview

7.3.2        Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Lactose Intolerance Tests

7.3.3.1          Overview

7.3.3.2          Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Breath Test for Bacterial Overgrowth

7.3.4.1          Overview

7.3.4.2          Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5        Stool Tests

7.3.5.1          Overview

7.3.5.2          Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6        Blood Tests

7.3.6.1          Overview

7.3.6.2          Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Imaging Tests

7.4.1        Overview

7.4.2        Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        CT-Scan or X-ray

7.4.3.1          Overview

7.4.3.2          CT-Scan or X-ray: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Upper Endoscopy

7.4.4.1          Overview

7.4.4.2          Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Colonoscopy

7.4.5.1          Overview

7.4.5.2          Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis – By Indication

8.1         Overview

8.2         Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)

8.3         Pain and Cramping

8.3.1        Overview

8.3.2        Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Diarrhea

8.4.1        Overview

8.4.2        Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Constipation

8.5.1        Overview

8.5.2        Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

8.6         Alternating Constipation & Diarrhea

8.6.1        Overview

8.6.2        Alternating Constipation & Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

9.           Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis and Forecasts To 2028 – South and Central America Analysis

9.1         South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market

9.1.1        Overview

9.1.2        South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)

9.1.3        Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1          Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2          Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1          Brazil: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.3.2.2          Brazil: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.3.3          Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.1.4        Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.4.1          Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.4.2          Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.1.4.2.1          Argentina: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.4.2.2          Argentina: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.4.3          Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

9.1.5        Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.1          Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.5.2          Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

9.1.5.2.1          Rest of South and Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.5.2.2          Rest of South and Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

9.1.5.3          Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

10.        Impact of COVID-19 Pandemic on South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market

10.1      South and Central America: Impact Assessment of COVID-19 Pandemic

11.        Irritable Bowel Syndrome (IBS) Diagnostics Market– Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

12.        Company Profiles

12.1      Commonwealth Diagnostics International

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Genova Diagnostics

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Inova Diagnostics, Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Biohit Oyj

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Aerodiagnostics, LLC.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Sysmex Corporation (Sysmex Europe GmbH)

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 2.             Brazil: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             Brazil: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             Argentina: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis – Revenue and Forecast to 2028 (USD Million)

Table 10.          Rest of South and Central America: Laboratory Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Rest of South and Central America: Imaging Tests Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication – Revenue and Forecast to 2028 (USD Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Glossary of Terms, Irritable Bowel Syndrome (IBS) Diagnostics Market

LIST OF FIGURES

Figure 1.           Irritable Bowel Syndrome (IBS) Diagnostics Market Segmentation

Figure 2.           Irritable Bowel Syndrome (IBS) Diagnostics Segmentation, By Country

Figure 3.           South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Overview

Figure 4.           Laboratory Tests Held Largest Share of Diagnosis Segment in Irritable Bowel Syndrome (IBS) Diagnostics Market

Figure 5.           Pain and Cramping Held Largest Share of Indication Segment in Irritable Bowel Syndrome (IBS) Diagnostics Market

Figure 6.           South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market– Leading Country Markets (US$ Million)

Figure 7.           SCAM: PEST Analysis

Figure 8.           Irritable Bowel Syndrome (IBS) Diagnostics Market Impact Analysis of Driver and Restraints

Figure 9.           South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)

Figure 11.        Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        CT-Scan or X-ray: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)

Figure 21.        Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Alternating Constipation & Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country – Revenue (2020) (USD Million)

Figure 26.        South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)

Figure 27.        Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Rest of the World

 

  1. Commonwealth Diagnostics International
  2. Genova Diagnostics
  3. Inova Diagnostics, Inc
  4. Biohit Oyj
  5. Aerodiagnostics, LLC.
  6. Sysmex Corporation (Sysmex Europe GmbH)
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America irritable bowel syndrome (ibs) diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America irritable bowel syndrome (ibs) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

 

TIPRE00022437
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing